BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 16263803)

  • 1. Nitric oxide synthase inhibition activates L- and T-type Ca2+ channels in afferent and efferent arterioles.
    Feng MG; Navar LG
    Am J Physiol Renal Physiol; 2006 Apr; 290(4):F873-9. PubMed ID: 16263803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II-mediated constriction of afferent and efferent arterioles involves T-type Ca2+ channel activation.
    Feng MG; Navar LG
    Am J Nephrol; 2004; 24(6):641-8. PubMed ID: 15627720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-type calcium channels in the regulation of afferent and efferent arterioles in rats.
    Feng MG; Li M; Navar LG
    Am J Physiol Renal Physiol; 2004 Feb; 286(2):F331-7. PubMed ID: 14583435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal nitric oxide synthase-dependent afferent arteriolar function in angiotensin II-induced hypertension.
    Ichihara A; Imig JD; Navar LG
    Hypertension; 1999 Jan; 33(1 Pt 2):462-6. PubMed ID: 9931148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular mechanisms mediating rat renal microvascular constriction by angiotensin II.
    Takenaka T; Suzuki H; Fujiwara K; Kanno Y; Ohno Y; Hayashi K; Nagahama T; Saruta T
    J Clin Invest; 1997 Oct; 100(8):2107-14. PubMed ID: 9329977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of T-type selective calcium antagonist on renal microcirculation: studies in the isolated perfused hydronephrotic kidney.
    Ozawa Y; Hayashi K; Nagahama T; Fujiwara K; Saruta T
    Hypertension; 2001 Sep; 38(3):343-7. PubMed ID: 11566902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ca2+ channel subtypes and pharmacology in the kidney.
    Hayashi K; Wakino S; Sugano N; Ozawa Y; Homma K; Saruta T
    Circ Res; 2007 Feb; 100(3):342-53. PubMed ID: 17307972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between endogenously produced carbon monoxide and nitric oxide in regulation of renal afferent arterioles.
    Botros FT; Navar LG
    Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H2772-8. PubMed ID: 16844915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EDRF-angiotensin II interactions in rat juxtamedullary afferent and efferent arterioles.
    Ohishi K; Carmines PK; Inscho EW; Navar LG
    Am J Physiol; 1992 Nov; 263(5 Pt 2):F900-6. PubMed ID: 1332506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactive nitric oxide-angiotensin II influences on renal microcirculation in angiotensin II-induced hypertension.
    Ichihara A; Imig JD; Inscho EW; Navar LG
    Hypertension; 1998 Jun; 31(6):1255-60. PubMed ID: 9622138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Divergent mechanisms of ATP-sensitive K+ channel-induced vasodilation in renal afferent and efferent arterioles. Evidence of L-type Ca2+ channel-dependent and -independent actions of pinacidil.
    Reslerova M; Loutzenhiser R
    Circ Res; 1995 Dec; 77(6):1114-20. PubMed ID: 7586223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superoxide anion curbs nitric oxide modulation of afferent arteriolar ANG II responsiveness in diabetes mellitus.
    Schoonmaker GC; Fallet RW; Carmines PK
    Am J Physiol Renal Physiol; 2000 Feb; 278(2):F302-9. PubMed ID: 10662734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-type voltage-gated calcium channels regulate the tone of mouse efferent arterioles.
    Poulsen CB; Al-Mashhadi RH; Cribbs LL; Skøtt O; Hansen PB
    Kidney Int; 2011 Feb; 79(4):443-51. PubMed ID: 21068717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KCl and angiotensin responses in isolated rat renal arterioles: effects of diltiazem and low-calcium medium.
    Conger JD; Falk SA
    Am J Physiol; 1993 Jan; 264(1 Pt 2):F134-40. PubMed ID: 8430823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Superoxide inhibits neuronal nitric oxide synthase influences on afferent arterioles in spontaneously hypertensive rats.
    Ichihara A; Hayashi M; Hirota N; Saruta T
    Hypertension; 2001 Feb; 37(2 Pt 2):630-4. PubMed ID: 11230347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal nitric oxide synthase modulates rat renal microvascular function.
    Ichihara A; Inscho EW; Imig JD; Navar LG
    Am J Physiol; 1998 Mar; 274(3):F516-24. PubMed ID: 9530268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient receptor potential channels in rat renal microcirculation: actions of angiotensin II.
    Takenaka T; Suzuki H; Okada H; Inoue T; Kanno Y; Ozawa Y; Hayashi K; Saruta T
    Kidney Int; 2002 Aug; 62(2):558-65. PubMed ID: 12110018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nebivolol-induced vasodilation of renal afferent arterioles involves β3-adrenergic receptor and nitric oxide synthase activation.
    Feng MG; Prieto MC; Navar LG
    Am J Physiol Renal Physiol; 2012 Sep; 303(5):F775-82. PubMed ID: 22674024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of chloride channels in afferent arteriolar constriction.
    Takenaka T; Kanno Y; Kitamura Y; Hayashi K; Suzuki H; Saruta T
    Kidney Int; 1996 Sep; 50(3):864-72. PubMed ID: 8872961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic deficit in nitric oxide elicits oxidative stress and augments T-type calcium-channel contribution to vascular tone of rodent arteries and arterioles.
    Howitt L; Kuo IY; Ellis A; Chaston DJ; Shin HS; Hansen PB; Hill CE
    Cardiovasc Res; 2013 Jun; 98(3):449-57. PubMed ID: 23436820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.